Coronavirus (1450) COVID-19 Vaccines The Factors that Enabled Unprecedented Timelines for Clinical Development and Regulatory Authorisation (2)

Reading the four key findings one still wonders what really hampers similar efforts for an HIV or other retroviral , viral, bacterial diseases in particular for those which are rampant in the poorer parts of the world. For some it is indeed more complex such as HIV but still the political and financial readiness we have never seen before applied to COVID-19 only. Or was it the potential very profitable market in the richer countries which played a role as well? I miss the sociologist or anthropological point of view.

But indeed very illustrative

Eric

Eric van Praag, MD, MPH

Health Systems and Community care Adviser

Dar es Salaam

Tanzania